MY125900A - Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders - Google Patents

Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders

Info

Publication number
MY125900A
MY125900A MYPI9904471A MY125900A MY 125900 A MY125900 A MY 125900A MY PI9904471 A MYPI9904471 A MY PI9904471A MY 125900 A MY125900 A MY 125900A
Authority
MY
Malaysia
Prior art keywords
cyclooxygenase
inhibitors
prevention
cardiovascular disorders
disorders
Prior art date
Application number
Inventor
Barbara Roniker
Richard J Lachapelle
Daniel T Connolly
Karen Seibert
Philip Needleman
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Priority to MYPI9904471 priority Critical patent/MY125900A/en
Publication of MY125900A publication Critical patent/MY125900A/en

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

THIS INVENTION RELATES TO THE USE OF CYCLOOXYGENASE-2 INHIBITORS OR DERIVATIVES THEREOF IN PREVENTING CARDIOVASCULAR DISORDERS.
MYPI9904471 1999-10-15 1999-10-15 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders MY125900A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI9904471 MY125900A (en) 1999-10-15 1999-10-15 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI9904471 MY125900A (en) 1999-10-15 1999-10-15 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders

Publications (1)

Publication Number Publication Date
MY125900A true MY125900A (en) 2006-08-30

Family

ID=47264570

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI9904471 MY125900A (en) 1999-10-15 1999-10-15 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders

Country Status (1)

Country Link
MY (1) MY125900A (en)

Similar Documents

Publication Publication Date Title
AP9901674A0 (en) Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders.
AU3652102A (en) Compounds and their uses
AU2001228309A1 (en) N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv
MY127247A (en) New pharmaceutical composition
HK1086762A1 (en) Sulfonamide substituted imidazoquinolines
HK1041407A1 (en) Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors.
AP2003002857A0 (en) New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors.
PL343904A1 (en) Compounds and methods for the inhibition of the expression of vcam-1
IL160630A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
PL370275A1 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MXPA03004794A (en) New mandelic acid derivatives and their use as throbin inhibitors.
MXPA03000066A (en) Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase.
WO2000066104A3 (en) Ace-2 inhibiting compounds and methods of use thereof
MXPA03000694A (en) New use of lipase inhibitors.
WO2001056573A8 (en) Use of cox-2 inhibitors as gastroprokinetics
ATE293691T1 (en) MYOSTATIN GENE PROMOTER AND INHIBITION OF ITS ACTIVATION
WO2003088748A8 (en) Use of heme oxygenase-1 and products of heme degradation
TW200505443A (en) Combination of SCR kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
WO1998022101A3 (en) Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
WO2002005848A3 (en) Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
WO2001056555A3 (en) Use of cox-2 inhibitors for the treatment of constipation
MY130792A (en) 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
ZA200502909B (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2.
HK1048318B (en) Substituted 3-phenyl-5-alkoxi-1, 3,4-oxdiazol-2-ones and their use as lipase inhibitors